Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease, and Heart Failure with Preserved Ejection Fraction: A Cardiopulmonary Perspective
- PMID: 31647719
- PMCID: PMC7049921
- DOI: 10.1164/rccm.201909-1780LE
Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease, and Heart Failure with Preserved Ejection Fraction: A Cardiopulmonary Perspective
Comment on
-
Could Adjunctive Pharmacology Mitigate Cardiovascular Consequences of Obstructive Sleep Apnea?Am J Respir Crit Care Med. 2019 Sep 1;200(5):551-555. doi: 10.1164/rccm.201811-2097PP. Am J Respir Crit Care Med. 2019. PMID: 30875238 Free PMC article. No abstract available.
References
-
- Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agustí A. Chronic obstructive pulmonary disease and cardiac diseases: an urgent need for integrated care. Am J Respir Crit Care Med. 2016;194:1319–1336. - PubMed
-
- Cazzola M, Matera MG, Rogliani P, Page C. Treating systemic effects of COPD. Trends Pharmacol Sci. 2007;28:544–550. - PubMed
-
- Plehn JF. The conundrum of patient selection in trials of heart failure with preserved ejection fraction: exploring the benefits and risks of focused phenotyping. J Card Fail. 2017;23:525–527. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
